Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,907.00
+18.00 (0.95%)
At close: Jun 12, 2026

Prestige Biologics Statistics

Total Valuation

KOSDAQ:334970 has a market cap or net worth of KRW 148.27 billion. The enterprise value is 232.70 billion.

Market Cap148.27B
Enterprise Value 232.70B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

KOSDAQ:334970 has 77.75 million shares outstanding. The number of shares has increased by 41.14% in one year.

Current Share Class 77.75M
Shares Outstanding 77.75M
Shares Change (YoY) +41.14%
Shares Change (QoQ) +0.22%
Owned by Insiders (%) 20.30%
Owned by Institutions (%) 0.22%
Float 30.85M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 8.22
PB Ratio 1.38
P/TBV Ratio 1.40
P/FCF Ratio 159.99
P/OCF Ratio 18.21
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 12.91
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 251.09

Financial Position

The company has a current ratio of 0.25, with a Debt / Equity ratio of 0.79.

Current Ratio 0.25
Quick Ratio 0.02
Debt / Equity 0.79
Debt / EBITDA n/a
Debt / FCF 91.82
Interest Coverage -6.58

Financial Efficiency

Return on equity (ROE) is -29.36% and return on invested capital (ROIC) is -13.14%.

Return on Equity (ROE) -29.36%
Return on Assets (ROA) -10.04%
Return on Invested Capital (ROIC) -13.14%
Return on Capital Employed (ROCE) -33.19%
Weighted Average Cost of Capital (WACC) 6.75%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.07
Inventory Turnover 1.42

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -49.95% in the last 52 weeks. The beta is 0.51, so KOSDAQ:334970's price volatility has been lower than the market average.

Beta (5Y) 0.51
52-Week Price Change -49.95%
50-Day Moving Average 2,162.56
200-Day Moving Average 2,860.89
Relative Strength Index (RSI) 44.39
Average Volume (20 Days) 128,886

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, KOSDAQ:334970 had revenue of KRW 18.03 billion and -35.42 billion in losses. Loss per share was -410.55.

Revenue18.03B
Gross Profit -18.88B
Operating Income -43.85B
Pretax Income -35.42B
Net Income -35.42B
EBITDA -28.62B
EBIT -43.85B
Loss Per Share -410.55
Full Income Statement

Balance Sheet

The company has 664.67 million in cash and 85.09 billion in debt, with a net cash position of -84.43 billion or -1,085.86 per share.

Cash & Cash Equivalents 664.67M
Total Debt 85.09B
Net Cash -84.43B
Net Cash Per Share -1,085.86
Equity (Book Value) 107.64B
Book Value Per Share 1,381.33
Working Capital -101.51B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.14 billion and capital expenditures -7.22 billion, giving a free cash flow of 926.76 million.

Operating Cash Flow 8.14B
Capital Expenditures -7.22B
Depreciation & Amortization 15.23B
Net Borrowing -10.84B
Free Cash Flow 926.76M
FCF Per Share 11.92
Full Cash Flow Statement

Margins

Gross margin is -104.71%, with operating and profit margins of -243.25% and -196.49%.

Gross Margin -104.71%
Operating Margin -243.25%
Pretax Margin -196.49%
Profit Margin -196.49%
EBITDA Margin -158.76%
EBIT Margin -243.25%
FCF Margin 5.14%

Dividends & Yields

KOSDAQ:334970 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -41.14%
Shareholder Yield -41.14%
Earnings Yield -23.89%
FCF Yield 0.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

KOSDAQ:334970 has an Altman Z-Score of -1.41 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.41
Piotroski F-Score 4